The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib. [electronic resource]
Producer: 20160830Description: 35087-94 p. digitalISSN:- 1949-2553
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- blood
- Disease-Free Survival
- Female
- Humans
- Kaplan-Meier Estimate
- L-Lactate Dehydrogenase -- blood
- Male
- Middle Aged
- Niacinamide -- analogs & derivatives
- Pancreatic Neoplasms -- blood
- Phenylurea Compounds -- therapeutic use
- Prognosis
- Sorafenib
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.